The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Epidemiology of Poliomyelitis in the United States One Decade after the Last Reported Case of Indigenous Wild Virus-Associated Disease
Abstract
Poliomyelitis caused by wild poliovirus has been virtually nonexistent in the United States since 1980, and vaccine-associated paralytic poliomyelitis (VAPP) has emerged as the predominant form of the disease. We reviewed national surveillance data on poliomyelitis for 1960-1989 to assess the changing risks of wild-virus, vaccine-associated, and imported paralytic disease; we also sought to characterize the epidemiology of poliomyelitis for the period 1980-1989. The risk of VAPP has remained exceedingly low but stable since the mid-1960s, with approximately 1 case occurring per 2.5 million doses of oral poliovirus vaccine (OPV) distributed during 1980-1989. Since 1980 no indigenous cases of wild-virus disease, 80 cases of VAPP, and five cases of imported disease have been reported in the United States. Three distinct groups are at risk of vaccine-associated disease: recipients of OPV (usually infants receiving their first dose), persons in contact with OPV recipients (mostly unvaccinated or inadequately vaccinated adults), and immunologically abnormal individuals. Overall, 93% of cases in OPV recipients and 76% of vaccine-associated cases have been related to administration of the first or second dose of OPV. Our findings suggest that adoption of a sequential vaccination schedule (inactivated poliovirus vaccine followed by OPV) would be effective in decreasing the risk of VAPP while retaining the proven public health benefits of OPV.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Geographic distribution of wild poliovirus type 1 genotypes
Rico-Hesse, R., Pallansch, M. A., Nottay, B. K., & Kew, O. M. (1987) · Virology · doi:10.1016/0042-6822(87)90001-8 · Cited by 328
Self-citationMucosal Immunity Induced by Enhanced-Potency Inactivated and Oral Polio Vaccines
Onorato, I. M., Modlin, J. F., McBean, A. M., Thoms, M. L., Losonsky, G. A., & Bernier, R. H. (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/163.1.1 · Cited by 246
Vaccine-associated paralytic poliomyelitis. United States: 1973 through 1984
Nkowane, B. M. (1987) · JAMA · doi:10.1001/jama.257.10.1335 · Cited by 240
Molecular variation of type 1 vaccine-related and wild polioviruses during replication in humans
Nottay, B. K., Kew, O. M., Hatch, M. H., Heyward, J. T., & Obijeski, J. F. (1981) · Virology · doi:10.1016/0042-6822(81)90448-7 · Cited by 190
Self-citationFaden, H., Modlin, J. F., Thoms, M. L., McBean, A. M., Ferdon, M. B., & Ogra, P. L. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/162.6.1291 · Cited by 178
Poliomyelitis in Hypogammaglobulinemics
Wyatt, H. V. (1973) · Journal of Infectious Diseases · doi:10.1093/infdis/128.6.802 · Cited by 167
Chronic progressive poliomyelitis secondary to vaccination of an immunodeficient child
Davis, L. E., Bodian, D., Price, D., Butler, I. J., & Vickers, J. H. (1977) · New England Journal of Medicine · doi:10.1056/nejm197708042970503 · Cited by 155
de Quadrós, C. A., Andrus, J. K., Olive, J. I., da Silveira, C. M., EIKHOF, R. M., Carrasco, P., Fitzsimmons, J. W., & Pinheiro, F. P. (1991) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199103000-00011 · Cited by 137
Natural variation of poliovirus neutralization epitopes
Crainic, R., Couillin, P., Blondel, B., Cabau, N., Boué, A., & Horodniceanu, F. (1983) · Infection and Immunity · doi:10.1128/iai.41.3.1217-1225.1983 · Cited by 110
HUMAN IMMUNODEFICIENCY VIRUS INFECTION AND ROUTINE CHILDHOOD IMMUNISATION
von Reyn, C. F., Clements, C. J., & Mann, J. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92451-2 · Cited by 109
Paralytic Disease Associated With Oral Polio Vaccines
Henderson, D. A., Witte, J. J., Morris, L., & Langmuir, A. D. (1964) · JAMA · doi:10.1001/jama.1964.03070140047006 · Cited by 108
Intratypic Serodifferentiation of Poliomyelitis Virus Strains by Strain-Specific Antisera
van Weze, A. L., & Hazendonk, A. G. (1979) · Intervirology · doi:10.1159/000149005 · Cited by 106
Christodoulou, C., Colbère-Garapin, F., Macadam, A. J., Taffs, L. F., Marsden, S. A., Minor, P. D., & Horaud, F. (1990) · Journal of Virology · doi:10.1128/jvi.64.10.4922-4929.1990 · Cited by 106
Live Virus Vaccines in Human Immunodeficiency Virus-Infected Children: A Retrospective Survey
McLaughlin, M., THOMAS, P. A., Onorato, I. M., Rubinstein, A., Oleske, J. M., Nicholas, S., Krasinski, K., Guigli, P., & Orenstein, W. A. (1988) · PEDIATRICS · doi:10.1542/peds.82.2.229 · Cited by 80
Self-citationVACCINE-ASSOCIATED POLIOMYELITIS IN THE UNITED STATES, 1961–19721
Schonberger, L. B., McGowan, J. E., & Gregg, M. B. (1976) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112290 · Cited by 75
Safety of oral poliomyelitis vaccine: results of a WHO enquiry.
Esteves, K. (1988) · Europe PMC (PubMed Central) · Cited by 61
Live or inactivated poliomyelitis vaccine: an analysis of benefits and risks.
Hinman, A. R., Koplan, J. P., Orenstein, W. A., Brink, E. W., & Nkowane, B. M. (1988) · American Journal of Public Health · doi:10.2105/ajph.78.3.291 · Cited by 58
Self-citationMinor, P. D., Schild, G. C., Ferguson, M. A. J., MacKay, A., Magrath, D. I., John, A., Yates, P. J., & Spitz, M. (1982) · Journal of General Virology · doi:10.1099/0022-1317-61-2-167 · Cited by 58
POLIOMYELITIS IN THE USA: VIRTUAL ELIMINATION OF DISEASE CAUSED BY WILD VIRUS
Kim-Farley, R., Schonberger, L., Nkowane, B. M., Kew, O., Bart, K. J., Orenstein, W. A., Hinman, A. R., Hatch, M. H., & Kaplan, J. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90829-8 · Cited by 51
Self-citationMcBean, A. M., & Modlin, J. F. (1987) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-198710000-00001 · Cited by 50
Monoclonal Antibodies to Polioviruses
Osterhaus, A. D. M. E., vanWezel, A. L., Hazendonk, T. G., UytdeHaag, F. G. C. M., van Asten, J. A. A. M., & van Steenis, B. (1983) · Intervirology · doi:10.1159/000149381 · Cited by 48
The case for global eradication of poliomyelitis.
(1987) · Europe PMC (PubMed Central) · Cited by 43
Control of Paralytic Poliomyelitis in the United States
Schonberger, L. B., Kaplan, J., Kim-Farley, R. J., Moore, M., EDDINS, D. L., & Hatch, M. H. (1984) · Clinical Infectious Diseases · doi:10.1093/clinids/6.supplement_2.s424 · Cited by 43
Polio vaccines: time for a change in immunisation policy?
Beale, A. J. (1990) · The Lancet · doi:10.1016/0140-6736(90)90945-2 · Cited by 35
Monitoring system for adverse events following immunization
Stetler, H. C., Mullen, J. R., Brennan, J.-P., Livengood, J. R., Orenstein, W. A., & Hinman, A. R. (1987) · Vaccine · doi:10.1016/0264-410x(87)90094-6 · Cited by 31
Self-citationEradication of indigenous poliomyelitis in Canada: impact of immunization strategies.
Varughese, P., Carter, A. O., Acres, S. E., & Furesz, J. (1989) · PubMed · Cited by 28
Monoclonal antibodies of four different specificities for neutralization of type 1 polioviruses
Humphrey, D. D., Kew, O. M., & Feorino, P. M. (1982) · Infection and Immunity · doi:10.1128/iai.36.2.841-843.1982 · Cited by 27
Self-citationGlezen, W. P., McCollough, R. H., Lamb, G. A., & Chin, T. D. Y. (1969) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a121058 · Cited by 27
Vaccine-Associated Paralytic Poliomyelitis
Querfurth, H. W. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530050061013 · Cited by 23
A new epidemiologic and laboratory classification system for paralytic poliomyelitis cases.
Sutter, R. W., Brink, E. W., Cochi, S. L., Kew, O., Orenstein, W. A., Biellik, R., & Hinman, A. R. (1989) · American Journal of Public Health · doi:10.2105/ajph.79.4.495 · Cited by 21
Self-citationNeurologic complications in oral polio vaccine recipients
Gaebler, J. W., Kleiman, M. B., French, L., Chastain, G., Barrett, C., & Griffin, C. (1986) · The Journal of Pediatrics · doi:10.1016/s0022-3476(86)80920-9 · Cited by 18
Cited by
Herd Immunity: History, Theory, Practice
Fine, P. E. M. (1993) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036121 · Cited by 905
VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION
Kew, O. M., Sutter, R. W., de Gourville, E. M., Dowdle, W. R., & Pallansch, M. A. (2005) · Annual Review of Microbiology · doi:10.1146/annurev.micro.58.030603.123625 · Cited by 703
Self-citationKew, O., Morris-Glasgow, V., Landaverde, M., Burns, C., Shaw, J., Garib, Z., André, J., Blackman, E., Freeman, C. J., Jorba, J., et al. (2002) · Science · doi:10.1126/science.1068284 · Cited by 600
Self-citationCurrent state and challenges in developing oral vaccines
Vela Ramirez, J. E., Sharpe, L. A., & Peppas, N. A. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.04.008 · Cited by 412
From Emergence to Eradication: The Epidemiology of Poliomyelitis Deconstructed
Nathanson, N., & Kew, O. M. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq320 · Cited by 404
Self-citation
Metadata
- Authors
- Strebel, P. M., Sutter, R. W., Cochi, S. L., Biellik, R. J., Brink, E. W., Kew, O. M., Pallansch, M. A., Orenstein, W. A., & Hinman, A. R.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1992-02-01
- Volume
- 14
- Issue
- 2
- Pages
- 568-579
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W1976988340
- Cited by
- 337
- References
- 31
- FWCI
- 13.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.